209 related articles for article (PubMed ID: 16541305)
1. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status.
McCann SE; Kulkarni S; Trevisan M; Vito D; Nie J; Edge SB; Muti P; Freudenheim JL
Breast Cancer Res Treat; 2006 Oct; 99(3):309-11. PubMed ID: 16541305
[TBL] [Abstract][Full Text] [Related]
2. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).
Cotterchio M; Boucher BA; Kreiger N; Mills CA; Thompson LU
Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574
[TBL] [Abstract][Full Text] [Related]
3. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer.
Touillaud MS; Pillow PC; Jakovljevic J; Bondy ML; Singletary SE; Li D; Chang S
Nutr Cancer; 2005; 51(2):162-9. PubMed ID: 15860438
[TBL] [Abstract][Full Text] [Related]
4. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
Zhang M; Yang H; Holman CD
Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980
[TBL] [Abstract][Full Text] [Related]
5. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
Touillaud MS; Thiébaut AC; Fournier A; Niravong M; Boutron-Ruault MC; Clavel-Chapelon F
J Natl Cancer Inst; 2007 Mar; 99(6):475-86. PubMed ID: 17374837
[TBL] [Abstract][Full Text] [Related]
6. Dietary mushroom intake and the risk of breast cancer based on hormone receptor status.
Shin A; Kim J; Lim SY; Kim G; Sung MK; Lee ES; Ro J
Nutr Cancer; 2010; 62(4):476-83. PubMed ID: 20432168
[TBL] [Abstract][Full Text] [Related]
7. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
Pietinen P; Stumpf K; Männistö S; Kataja V; Uusitupa M; Adlercreutz H
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):339-44. PubMed ID: 11319174
[TBL] [Abstract][Full Text] [Related]
8. Dietary lignan intakes and risk of pre- and postmenopausal breast cancer.
McCann SE; Muti P; Vito D; Edge SB; Trevisan M; Freudenheim JL
Int J Cancer; 2004 Sep; 111(3):440-3. PubMed ID: 15221974
[TBL] [Abstract][Full Text] [Related]
9. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
Piller R; Chang-Claude J; Linseisen J
Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
[TBL] [Abstract][Full Text] [Related]
10. The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study.
Zaineddin AK; Buck K; Vrieling A; Heinz J; Flesch-Janys D; Linseisen J; Chang-Claude J
Nutr Cancer; 2012; 64(5):652-65. PubMed ID: 22591208
[TBL] [Abstract][Full Text] [Related]
11. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
12. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
Anderson LN; Cotterchio M; Boucher BA; Kreiger N
Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
[TBL] [Abstract][Full Text] [Related]
13. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
[TBL] [Abstract][Full Text] [Related]
14. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
[TBL] [Abstract][Full Text] [Related]
15. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
Hedelin M; Bälter KA; Chang ET; Bellocco R; Klint A; Johansson JE; Wiklund F; Thellenberg-Karlsson C; Adami HO; Grönberg H
Prostate; 2006 Oct; 66(14):1512-20. PubMed ID: 16921512
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrates and the risk of breast cancer among Mexican women.
Romieu I; Lazcano-Ponce E; Sanchez-Zamorano LM; Willett W; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1283-9. PubMed ID: 15298947
[TBL] [Abstract][Full Text] [Related]
17. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
[TBL] [Abstract][Full Text] [Related]
18. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study.
Deandrea S; Talamini R; Foschi R; Montella M; Dal Maso L; Falcini F; La Vecchia C; Franceschi S; Negri E
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2025-8. PubMed ID: 18708394
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai.
Dai Q; Franke AA; Jin F; Shu XO; Hebert JR; Custer LJ; Cheng J; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):815-21. PubMed ID: 12223424
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
